# The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants

> **NCT03535883** · — · COMPLETED · sponsor: **Yale University** · enrollment: 590 (actual)

## Conditions studied

- Pleural Effusion
- Thoracic Effusion

## Interventions

- **DRUG:** Novel Oral Anti-Coagulants

## Key facts

- **NCT ID:** NCT03535883
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-30
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 590 (ACTUAL)
- **Last updated:** 2023-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03535883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03535883, "The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03535883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*